OKYO Pharma Limited (OKYO)

AI Score

Unlock

1.22

0.09 (7.97%)

At close: Apr 17, 2025, 3:46 PM

1.17

-3.84%

After-hours: Apr 17, 2025, 06:52 PM EDT

OKYO Pharma Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q2 2025	Q1 2025	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Jun 30, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016	Sep 30, 2015
Cash & Equivalents	987.2K	987.2K	n/a	n/a	4.05M	3.35M	707.57K	633.63K	2.7M	5.17M	6.89M	7.41M	234.96K	67.17K	627.56K	1.62M	n/a	3.57M	n/a	4.49M	5.13M	5.97M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	-4.05M	0.00	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.00	n/a	1.00	1.00	1.00
Receivables	n/a	n/a	n/a	n/a	980.08K	n/a	-165.44K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47.65	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	170.31K	n/a	4.7K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.52M	1.52M	n/a	n/a	n/a	810.74K	516.2K	487.88K	n/a	238.14K	76.28K	50.14K	263.09K	518.24K	85.46K	n/a	n/a	127.66K	n/a	124.29K	113.79K	156.76K
Total Current Assets	2.83M	2.83M	n/a	4.05M	5.2M	4.3M	1.77M	1.58M	4.3M	5.52M	6.99M	7.48M	566.73K	615.87K	758.75K	1.64M	47.65	3.8M	16.86M	4.73M	5.37M	6.3M
Property-Plant & Equipment	2.16K	2.16K	n/a	n/a	7.22K	5.97K	5.62K	5.03K	5.22K	85.8K	104.64K	30.29K	30.66K	835.85	1.1K	n/a	n/a	56.96K	n/a	15.7M	17.16M	17.88M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.75M	9.65M	10.17M
Total Long-Term Assets	2.16K	2.16K	n/a	-4.05M	7.22K	5.97K	5.62K	5.03K	5.22K	85.8K	104.64K	30.29K	30.66K	835.85	1.1K	n/a	n/a	56.96K	n/a	24.44M	26.81M	28.06M
Total Assets	2.83M	2.83M	n/a	n/a	5.2M	4.3M	1.77M	1.59M	4.3M	5.61M	7.09M	7.51M	597.4K	616.7K	759.86K	1.64M	n/a	3.85M	n/a	29.17M	32.18M	34.35M
Account Payables	9.61M	9.61M	n/a	n/a	1.02M	1.98M	1.24M	1.36M	517.67K	215.56K	210.99K	213.44K	593.72K	778.85K	381.76K	89.91K	n/a	291.63K	141.79K	171.08K	124.12K	216.75K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	1.00	n/a	n/a	n/a	1.00	n/a	0.94	-0.11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.81K	1.81K	n/a	n/a	1.8M	1.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	445.63K	445.63K	n/a	n/a	1.71M	n/a	284.74K	0.00	323.06K	339.48K	1.46M	154.16K	-26.73K	31.27K	-1.13K	50.71K	87.59K	-80.02K	1.00	51.84K	16.95K	-75.34K
Total Current Liabilities	10.05M	10.05M	n/a	n/a	7.26M	6M	2.12M	1.9M	1.35M	617.29K	1.71M	417.07K	710.66K	812.5K	426.72K	218.12K	n/a	315.6K	n/a	223.57K	181.34K	221.51K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	2.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	2.05M	n/a	n/a	n/a	n/a	n/a	47.12K	64.61K	23.83K	26.54K	n/a	n/a	n/a	n/a	n/a	n/a	-651.5	n/a	n/a
Total Liabilities	10.05M	10.05M	n/a	2.05M	7.26M	6M	2.12M	1.9M	1.35M	664.41K	1.77M	440.91K	737.2K	812.5K	426.72K	218.12K	n/a	315.6K	n/a	222.92K	181.34K	221.51K
Total Debt	1.81K	1.81K	n/a	n/a	2.22M	1.83M	n/a	n/a	n/a	81.55K	98.76K	28.97K	31.62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	131.39M	n/a	87.85M	n/a	123.98M	102.54M	111.63M	86.36M	n/a	84.57M	89.22M	86.47M	n/a	88.68M	n/a	n/a	95.12M	100.31M
Retained Earnings	-145.2M	-145.2M	n/a	n/a	-125.7M	-103.98M	-90.9M	-81.4M	-112.43M	-99.97M	-106M	-90.55M	-85.88M	-84.93M	-88.97M	-85.53M	n/a	-85.12M	n/a	-58.8M	-64.71M	-67.99M
Comprehensive Income	-6.07M	-6.07M	n/a	-2.05M	-11.45M	-6.4M	-58.34K	2.43M	-11.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-14.04K	n/a	n/a	-276.54K	-107.17K
Shareholders Equity	-7.23M	-7.23M	n/a	-2.05M	-2.05M	-1.7M	-345.82K	-309.68K	2.95M	4.94M	5.32M	7.07M	-139.8K	-195.8K	333.14K	1.42M	n/a	3.54M	n/a	28.95M	32M	34.13M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.86M	n/a	n/a	n/a